From delays to detection: AI and digital labs power India’s shift to preventive healthcare

India’s diagnostic sector is undergoing a rapid transformation as artificial intelligence (AI) and digital technologies begin to address long-standing gaps in early disease detection. With a rising burden of chronic illnesses and a shortage of specialists, healthcare providers are increasingly turning to automation, data analytics and predictive tools to improve outcomes and expand access.

Specialist shortage, rising disease burden drive tech adoption

Dr. Anand K, CEO and MD, Agilus Diagnostics said the integration of technology is fundamentally reshaping early disease detection in India particularly in the face of a severe shortage of specialists.

“In a country of over 1.4 billion people, one of our biggest healthcare challenges is the acute shortage of specialists. For instance, India faces a deficit of nearly 15,000 radiologists, creating significant delays in diagnosing critical conditions. AI enabled interpretation tools can play a key role in supporting clinicians by rapidly analysing X ray images and reducing diagnostic bottlenecks,” he said.

He highlighted that early detection has become critical as chronic diseases—especially cardiovascular illnesses—account for nearly 28% of all deaths in India. Many cases worsen due to delayed diagnosis, but timely screening and technology-driven interventions can significantly improve outcomes.

Technology is also helping bridge the urban-rural healthcare divide. “Nearly 65–70% of India’s population resides in rural areas, where access to specialist care and advanced diagnostic infrastructure remains limited. Digital platforms, telemedicine, and tech enabled laboratory networks are bridging this divide,” he added.

Dr. Anand K also pointed to the growing role of predictive healthcare. By analysing medical records and imaging data, AI can identify high-risk individuals even before symptoms appear, marking a shift from reactive treatment to proactive prevention.

Digital labs cut turnaround time, boost efficiency

The rise of digital laboratories is further accelerating this shift. Dr. Shalini Singh, Director of Lab Operations at Ampath said the diagnostic sector is witnessing a major transition from manual workflows to automation-led systems.

“Traditionally, laboratory workflows relied heavily on manual intervention across multiple stages from sample processing and testing to validation and report generation which often resulted in longer turnaround times,” she noted.

With automation and AI-driven analytics, laboratories are now able to process high volumes of tests more efficiently while maintaining quality standards. “Automated sample handling, integrated laboratory information systems, and intelligent data analysis tools allow high volumes of tests to be processed with greater efficiency,” she said.

A key benefit has been faster report delivery. “In many cases, results that previously took days can now be delivered within hours. This is particularly important in clinical scenarios where timely diagnosis directly impacts treatment decisions,” she added, citing cardiac markers, infection panels, and critical blood investigations.

Dr. Singh also emphasised the importance of preventive healthcare. “India is witnessing a crucial shift from reactive to preventive healthcare, but there is still a long way to go. We strongly advocate for annual diagnostic screenings as a proactive step toward early detection and better health outcomes,” she said, adding that routine testing can help detect conditions like diabetes, cardiovascular diseases, and certain cancers at an early stage.

AI complements, not replaces, traditional diagnostics

Experts stress that while AI is transforming diagnostics, it is not a substitute for clinical expertise. Dr. Maneesh Bagai, Chief Operating Officer at Ampath, said AI should be viewed as an enabler rather than a replacement.

“Artificial Intelligence is not a replacement for traditional diagnostics; rather, it is a powerful enabler that enhances the accuracy, efficiency, and predictive capability of modern laboratories,” he said.

AI systems can analyse large datasets, patient histories, and biomarker patterns at a scale that manual processes cannot match. This helps identify subtle variations that may indicate early disease onset, particularly in areas such as oncology screening, metabolic disorders, and cardiac risk profiling.

However, Dr. Bagai underscored that technology works best alongside human expertise. “AI works best as a decision-support tool that strengthens clinical judgement while improving consistency and reducing human error,” he said.

As India’s healthcare ecosystem evolves, the integration of AI with traditional diagnostics is expected to play a pivotal role in advancing preventive healthcare and improving access to early detection.